Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Arrowhead Pharmaceuticals (ARWR) Q2 2026 Earnings
ARWR
7
May
Confirmed
Q3 2025
Q4 2025
Q1 2026
Q2 2026
-1.26
-0.77
-0.27
0.22
Details
Expected EPS
-1.094596
Actual EPS
-0.93
Surprise EPS
0.16
Surprise Percent
+15.04%
Description
Arrowhead Pharmaceuticals (ARWR) has reported earnings of -0.93 per share for Q2 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login